Jesús
García Mata
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (11)
2020
-
The economic burden of metastatic breast cancer in Spain
European Journal of Hospital Pharmacy , Vol. 27, Núm. 1, pp. 19-24
2018
-
A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain
Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 1061-1071
2010
-
Current controversies in the management of breast cancer
Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286
-
Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))
Clinical and Translational Oncology
-
Supportive care for patients with early breast cancer
Clinical and Translational Oncology, Vol. 12, Núm. 1, pp. 32-42
2008
-
Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
Clinical and Translational Oncology, Vol. 10, Núm. 11, pp. 739-744
2007
-
Advanced breast cancer: Chemotherapy phase III trials that change a standard
Anti-Cancer Drugs
-
Current controversies in the management of early breast cancer
Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 375-384
-
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial
Lancet Oncology, Vol. 8, Núm. 3, pp. 219-225
-
The use of taxanes in the neoadjuvant treatment of breast cancer: A review of randomized phase II/III trials
Clinical Breast Cancer, Vol. 7, Núm. 10, pp. 764-774